Facet Solutions Enjoys Continued Clinical Success With the Anatomic Facet Replacement System ...( LOGAN Utah Oct. 19 /- Facet Solut...),Health

LOGAN, Utah, Oct. 19 /PRNewswire/ -- Facet Solutions, Inc. announced today that John Regan, M.D., a board-certified orthopedic surgeon at Century City Doctors Hospital in Los Angeles, California; and Darryl DiRisio, M.D., associate professor and neurosurgeon at Albany Medical College, Albany, New York, successfully completed additional surgical procedures utilizing the company's Anatomic Facet Replacement System (AFRS(TM)) as part of an FDA approved IDE Clinical Trial.

The AFRS(TM) is the first anatomic facet replacement device designed to provide patients with lumbar spinal stenosis and facet degeneration a motion preserving alternative to fusion.

A fusion uses metal rods and screws to join vertebrae together. While most patients report pain relief after a spinal fusion, the surgery often eliminates flexibility and range of motion, and can cause unnecessary wear on other spinal levels. By contrast, the AFRS(TM) is designed to mimic normal motion and prevent adjacent level degeneration.

The AFRS(TM) is made of two highly polished cobalt chrome implants that articulate similar to other total joints that have been used successfully in hip and knee replacements for several decades

"Until recently, people suffering from chronic lower back pain caused by lumbar spinal stenosis had few treatment options," stated Dr. Regan. "Facet joint replacement utilizing the AFRS(TM) not only relieves low back pain but also has the potential to significantly improve the patients' flexibility and range of motion.

Dr. DiRisio noted that the use of facet joint replacement for the treatment of spinal stenosis following a spinal decompression is a notable advance in spinal surgery. "It offers surgeons an alternative treatment for patients who have suffered for years from this debilitating condition."

The public response overall to the AFRS(TM) clinical trial has been very strong. New clinical investigator, Kenneth Pettine, M.D., board-certified ort
'/>"/>